Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-25 @ 7:09 PM
Study NCT ID:
NCT03567304
Status:
UNKNOWN
Last Update Posted:
2019-07-24
First Post:
2018-06-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine
Sponsor:
Chiang Mai University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-07
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-07
First Submit QC Date:
None
Study First Post Date:
2018-06-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-22
Last Update Post Date:
2019-07-24
Last Update Post Date Type:
ACTUAL